Aqua Bio Technology A Current Liabilities
The Current Liabilities of Aqua Bio Technology A (ABTEC.OL) as of Oct 21, 2026 is 9.00 M NOK. In the previous year, Current Liabilities was 172.19 M NOK — a change of -94.78% (lower).
Get this data via API
Financial Data API
Current Liabilities
9.00 MNOK
YoY
-94.78%
Last updated:
The Aqua Bio Technology A Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 9.00 MNOK | -94.78% | |
| 172.19 MNOK | +101.47% | |
| 85.47 MNOK | +317.48% | |
| 20.47 MNOK | +86.86% | |
| 10.96 MNOK | +467.25% | |
| 1.93 MNOK | — | |
| 0.00NOK | — | |
| 0.00NOK | — | |
| 0.00NOK | — | |
| 0.00NOK | -100.00% | |
| 2.78 MNOK | +6.45% | |
| 2.61 MNOK | -75.00% | |
| 10.43 MNOK | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Aqua Bio Technology A Stock analysis
Frequently Asked Questions about Aqua Bio Technology A stock
Current Liabilities of Aqua Bio Technology A is 9.00 M NOK in 2025.
Current Liabilities of Aqua Bio Technology A changed from 172.19 M NOK to 9.00 M NOK, representing a -94.78% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Aqua Bio Technology A since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Aqua Bio Technology A historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Aqua Bio Technology A
All Key Metrics — Aqua Bio Technology A
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth